Kenvue Inc. Total Liabilities
Kenvue Inc. total liabilities. Based on the latest financial reports, Kenvue Inc. (KVUE) has total liabilities worth $16.61 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Kenvue Inc. to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Kenvue Inc. (2020–2024)
Total liabilities of Kenvue Inc. from 2020 to 2024. This chart illustrates how Kenvue Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Kenvue Inc. Competitors by Total Liabilities
The table below lists competitors of Kenvue Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vestas Wind Systems A/S
CO:VWS
|
Denmark | Dkr22.79 Billion |
|
Roblox Corp
NYSE:RBLX
|
USA | $8.20 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $13.24 Billion |
|
Bajaj Finserv Limited
NSE:BAJAJFINSV
|
India | Rs-1.41 Trillion |
|
Transurban Group
AU:TCL
|
Australia | AU$25.55 Billion |
|
Steel Dynamics Inc
NASDAQ:STLD
|
USA | $7.59 Billion |
|
adidas AG
F:ADS
|
Germany | €14.11 Billion |
|
Orix Corp Ads
F:OIXA
|
Germany | €13.41 Trillion |
Liability Composition Analysis (2020–2024)
This chart breaks down Kenvue Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Kenvue Inc. (KVUE) total assets.
Liquidity & Leverage Metrics
Kenvue Inc. Total Liabilities Ratios Explained
Kenvue Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kenvue Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kenvue Inc. (2020–2024)
The table below shows the annual total liabilities of Kenvue Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $15.93 Billion | -4.25% |
| 2023-12-31 | $16.64 Billion | +126.52% |
| 2022-12-31 | $7.35 Billion | -2.44% |
| 2021-12-31 | $7.53 Billion | -30.41% |
| 2020-12-31 | $10.82 Billion | -- |
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, … Read more